These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33493605)

  • 1. Optimization of sulfobutyl-ether-β-cyclodextrin levels in oral formulations to enhance progesterone bioavailability.
    Shankar VK; Police A; Pandey P; Cuny ZG; Repka MA; Doerksen RJ; Murthy SN
    Int J Pharm; 2021 Mar; 596():120212. PubMed ID: 33493605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
    Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.
    Jain AS; Date AA; Pissurlenkar RR; Coutinho EC; Nagarsenker MS
    AAPS PharmSciTech; 2011 Dec; 12(4):1163-75. PubMed ID: 21918921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxypropyl-sulfobutyl-β-cyclodextrin improves the oral bioavailability of edaravone by modulating drug efflux pump of enterocytes.
    Rong WT; Lu YP; Tao Q; Guo M; Lu Y; Ren Y; Yu SQ
    J Pharm Sci; 2014 Feb; 103(2):730-42. PubMed ID: 24311389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloramphenicol/sulfobutyl ether-β-cyclodextrin complexes in an ophthalmic delivery system: prolonged residence time and enhanced bioavailability in the conjunctival sac.
    Xu Y; Zhang C; Zhu X; Wang X; Wang H; Hu G; Fu Q; He Z
    Expert Opin Drug Deliv; 2019 Jun; 16(6):657-666. PubMed ID: 31033370
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparation and pharmacokinetic study of aprepitant-sulfobutyl ether-β-cyclodextrin complex.
    Ren L; Zhou Y; Wei P; Li M; Chen G
    AAPS PharmSciTech; 2014 Feb; 15(1):121-30. PubMed ID: 24166668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion Complex of Isoliquiritigenin With Sulfobutyl Ether-β-Cyclodextrin: Preparation, Characterization, Inclusion Mode, Solubilization, and Stability.
    Wu X; Li J; Hu C; Zheng Y; Zhang Y; Li J; Li M; Xiao D; Lu L; Huang Y; Zhang X; Li C
    Front Chem; 2022; 10():930297. PubMed ID: 35800032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sulfobutyl ether-β-cyclodextrin and propylene glycol alginate on the solubility of clozapine.
    Furuishi T; Sekino K; Gunji M; Fukuzawa K; Nagase H; Endo T; Ueda H; Yonemochi E
    Pharm Dev Technol; 2019 Apr; 24(4):479-486. PubMed ID: 30126299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion Complex of Docetaxel with Sulfobutyl Ether β-Cyclodextrin: Preparation, In Vitro Cytotoxicity and In Vivo Safety.
    Ren L; Yang X; Guo W; Wang J; Chen G
    Polymers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
    Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
    Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfo-butyl ether β-cyclodextrin inclusion complexes of bosutinib: in silico, in vitro and in vivo evaluation in attenuating the fast-fed variability.
    Shah S; Famta P; Vambhurkar G; Bagasariya D; Kumar KC; Srinivasarao DA; Begum N; Sharma A; Shahrukh S; Jain N; Khatri DK; Srivastava S
    Drug Deliv Transl Res; 2024 May; 14(5):1218-1231. PubMed ID: 37903963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics.
    Li J; Jiang Q; Deng P; Chen Q; Yu M; Shang J; Li W
    J Pharm Pharmacol; 2017 Jun; 69(6):663-674. PubMed ID: 28299800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms.
    Savolainen J; Järvinen K; Taipale H; Jarho P; Loftsson T; Järvinen T
    Pharm Res; 1998 Nov; 15(11):1696-701. PubMed ID: 9833990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
    Zhang X; Zhang T; Lan Y; Wu B; Shi Z
    AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
    Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
    J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
    Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether beta-cyclodextrin.
    Nagase Y; Hirata M; Wada K; Arima H; Hirayama F; Irie T; Kikuchi M; Uekama K
    Int J Pharm; 2001 Oct; 229(1-2):163-72. PubMed ID: 11604269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of a sulfobutyl ether beta-cyclodextrin enabled etomidate formulation.
    McIntosh MP; Schwarting N; Rajewski RA
    J Pharm Sci; 2004 Oct; 93(10):2585-94. PubMed ID: 15349968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and Characterization of the Sulfobutylether-β-Cyclodextrin Inclusion Complex of Amiodarone Hydrochloride with Enhanced Oral Bioavailability in Fasted State.
    Wang D; Chen G; Ren L
    AAPS PharmSciTech; 2017 Jul; 18(5):1526-1535. PubMed ID: 27757923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.
    Spamer E; Müller DG; Wessels PL; Venter JP
    Eur J Pharm Sci; 2002 Sep; 16(4-5):247-53. PubMed ID: 12208454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.